Investors

Newbury Ventures
Newbury Ventures is an international venture capital group focused on investing in and growing entrepreneurial companies in the communication and information technology sectors. The firm specializes in identifying opportunities for significant capital appreciation, by investing in promising entrepreneurial companies at early stages of their corporate development. Newbury's partners have financed well over 100 successful emerging growth technology companies, with over a third conceived and built to leverage the binational investment model using multinational skills and resources. Newbury has recently closed its third fund at $250 million.

Polaris Venture Partners
Established in 1996, with offices in Waltham and Seattle, Polaris has over $3 billion under management. Polaris Venture Partners have helped build numerous market leading companies, including Accordant Health Services, Advanced Inhalation Research, Akamai Technologies, Allaire, Alnylam Pharmaceuticals, American Superconductor, Aspect Medical Systems, Avici Systems, Centra Software, Classifieds2000, deCODE genetics, Exchange.com, Matrics, Microbia, Momenta Pharmaceuticals, Paradigm Genetics, Powersoft, PSCI, SolidWorks and TransForm Pharmaceuticals.

St. Paul Venture Capital
St. Paul Venture Capital is one of the largest early-stage venture capital firms in the United States with $3.0 billion in committed capital and offices in Minneapolis, Boston, and Silicon Valley. The firm, founded in 1988, invests primarily in the areas of Communications, Business Internet, Consumer Technology, and Health Care.

Merrill Lynch Ventures, LP 2001
Merrill Lynch Ventures is a private equity investment entity affiliated with Merrill Lynch & Co., Inc. Merrill Lynch Ventures seeks minority interest positions in privately offered equity investments in both U.S. and non-U.S. issuers. Target investments include securities in conjunction with financing of companies in an early stage of development, primarily in the technology, telecommunications, and healthcare industries. Additional target investments include securities issued in conjunction with leveraged buyouts, investments in growth equities, and transactions involving financial restructuring reorganization.

Wall Street Technology Partners
Wall Street Technology Partners LP (WSTP) is a New York-based technology fund founded in 2000.  The fund invests in mid-to-late stage US-based technology and media companies across a wide industry spectrum, including software applications, servers and storage, semiconductors, wireless, telecom systems and enterprise and carrier networks. WSTP has in excess of $100 million of capital under management. Its limited partners include institutional investors, funds of funds and high net worth individuals. The team of four partners has collectively sourced, structured and invested in over 70 venture capital and buyouts transactions. WSTP is a value-added partner leveraging an expansive network to help build great companies. The fund has worked extensively with over 100 well-known private equity funds and strategic partners.

Intersouth Partners
Located in Durham, North Carolina, Intersouth Partners is one of the largest and most experienced early-stage venture funds in the Southeast, having invested in over sixty private companies, primarily in the Internet, information technology, and life sciences sectors. Founded in 1985, Intersouth Partners manages $300 million in five venture capital limited partnerships. Intersouth has an experienced team and is held in high regard among limited partners, entrepreneurs, other venture capitalists, and relevant service providers. Their partners have full-cycle experience in the complex matters associated with investing in fledgling companies, including management team development, technology assessment and transfer, corporate partnering, and successful exits. Intersouth's limited partners include well-known institutional investors, as well as successful entrepreneurs, and business leaders.

First Consulting Group
First Consulting Group is a leading provider of information-based consulting, integration and management services for healthcare, pharmaceutical, and other life sciences organizations in North America and Europe. The firm's services are designed to increase its clients' operations effectiveness, resulting in reduced costs, improved customer service, enhanced quality of patient care, and the more rapid introduction of new pharmaceutical compounds. More information about FCG is available by calling 800-345-0957.